Market News
Stay updated with the latest market trends, earnings, and economic indicators.
AstraZeneca Pharma India Q4 profit drops 23% despite strong revenue growth
Oncology, biopharma growth drive FY26 performance; board recommends ₹36/share dividend
Stocks to Watch Today: Swiggy, Enviro Infra, Advait Energy, AstraZeneca, Torrent Pharma, Laxmi Organic,... - Moneycontrol.com
Stocks to Watch Today: Swiggy, Enviro Infra, Advait Energy, AstraZeneca, Torrent Pharma, Laxmi Organic,...Moneycontrol.com
AstraZeneca Pharma gets CDSCO nod to import leukaemia drug Calquence 100 mg tablets
Following the approval, acalabrutinib tablets 100 mg in combination with venetoclax with or without obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL). Shares of Astrazeneca Pharma India Ltd ended at ₹8,291.50, up by ₹235.70, or 2.93%, on the BSE today, April 10.
AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 crore
The land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva Group, Aurobindo Pharma and RMZ. The company is looking to sell it as part of a broader land monetisation strategy.
Stocks to Watch Today: Swiggy, Enviro Infra, Advait Energy, AstraZeneca, Torrent Pharma, Laxmi Organic, Larsen & Toubro, Safety Controls in focus on 13 April
Stocks to Watch, 13 Apr: Stocks like Mahindra and Mahindra, Larsen & Toubro, Swiggy, Enviro Infra Engineers, Advait Energy Transitions, Mahanagar Gas, Krishna Defence and Allied Industries, Lupin, AstraZeneca Pharma India, Torrent Pharmaceuticals, Muthoot Finance, and Ratnaveer Precision Engineering will be in focus on April 13.